Suppliers / Takeda Pharmaceutical

Takeda Pharmaceutical

Japan 5 duplicate records merged Updated 9 July 2026

Takeda Pharmaceutical is an API manufacturer based in Japan. It appears in 28 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and NMPA (CN). Its GMP standing is certified by MFDS (Korea).

0
active US DMFs
0
valid CEPs
0
registered plants
28
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Azilsartan Medoxomil SFDA (Saudi Arabia) 1
Candesartan Cilexetil SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 24 None
NMPA (CN) 4 None
MFDS (Korea) None 4

Comparing suppliers?

Choose your molecules and target markets. Takeda Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates